WO2018214812A1 - 用作自噬调节剂的化合物及其制备方法和用途 - Google Patents

用作自噬调节剂的化合物及其制备方法和用途 Download PDF

Info

Publication number
WO2018214812A1
WO2018214812A1 PCT/CN2018/087446 CN2018087446W WO2018214812A1 WO 2018214812 A1 WO2018214812 A1 WO 2018214812A1 CN 2018087446 W CN2018087446 W CN 2018087446W WO 2018214812 A1 WO2018214812 A1 WO 2018214812A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
substituted
unsubstituted
fluorenyl
membered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2018/087446
Other languages
English (en)
French (fr)
Chinese (zh)
Inventor
罗成
谢雨礼
周兵
姚志艺
乐立艳
万伟
张碧东
张元元
蒋华良
陈凯先
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Autopharm Biopharmaceutical Co Ltd
Original Assignee
Suzhou Autopharm Biopharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou Autopharm Biopharmaceutical Co Ltd filed Critical Suzhou Autopharm Biopharmaceutical Co Ltd
Priority to US16/614,465 priority Critical patent/US11319303B2/en
Priority to MX2019013816A priority patent/MX2019013816A/es
Priority to AU2018274378A priority patent/AU2018274378B2/en
Priority to BR112019024376-3A priority patent/BR112019024376A2/pt
Priority to CA3061209A priority patent/CA3061209A1/en
Priority to CN201880033785.9A priority patent/CN111148740B/zh
Priority to KR1020197036203A priority patent/KR102580087B1/ko
Priority to EP18805508.1A priority patent/EP3632903B1/en
Priority to JP2019565459A priority patent/JP7237017B2/ja
Priority to CN202310882957.2A priority patent/CN116969904A/zh
Publication of WO2018214812A1 publication Critical patent/WO2018214812A1/zh
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
    • C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C225/18—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings the carbon skeleton containing also rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/24—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/14—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of carbon skeletons containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/36—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • C07C239/14—Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/04—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/06—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
    • C07C251/08—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton being acyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/12—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms
    • C07C321/20—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/24—Thiols, sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
    • C07C321/28—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
    • C07C321/30—Sulfides having the sulfur atom of at least one thio group bound to two carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/385—Saturated compounds containing a keto group being part of a ring
    • C07C49/403—Saturated compounds containing a keto group being part of a ring of a six-membered ring
    • C07C49/407—Menthones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/527—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings
    • C07C49/563—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/527—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings
    • C07C49/573—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings containing hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/68—One oxygen atom attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/58—Nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C07D295/116—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings with the doubly bound oxygen or sulfur atoms directly attached to a carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D309/06—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/56—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/54—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/36—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/167—Purine radicals with ribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Definitions

  • the invention relates to the field of biomedicine, and in particular to a class of autophagy regulators, in particular mammalian ATG8 homolog regulators and uses thereof.
  • Autophagy is a pathway for intracellular degradation. It is a process in which proteins and organelles that are damaged or lose function in the cell are transported to lysosomes for digestion and degradation. In biological evolution, autophagy is a conserved process, from yeast to plant cells to mammalian cells.
  • autophagy plays an important role in providing nutrients, clearing cell contents, antigen presentation, etc. while maintaining physiological functions such as starvation, and plays an important role in cancer, infectious diseases, and neurodegenerative diseases. character of. Autophagy plays a double-edged sword in the development of tumors: In the early stage of tumorigenesis, autophagy defects increase genomic instability and promote carcinogenesis; rapid tumor growth and metastasis, autophagy can resist stress Conditions inhibit anoikis and maintain tumor cell survival. Although the relationship between autophagy and tumors varies at different stages of tumor development, the development of autophagy regulators will be of great value for advanced cancers and chemotherapy-resistant cancers.
  • small molecule modulators targeting autophagy are mainly limited to mTOR and lysosomal modulators, and studies on small molecule modulators such as ATG4 and ULK1 are still in the early stages of development.
  • the most important autophagy-related proteins, ATG8 and its mammalian homologous family of proteins, LC3, GABARAP and GATE-16 subfamily have not been reported.
  • the LC3 family has LC3A, LC3B, and LC3C
  • the GABARAP family has GABARAPL and GABARAPLl
  • the GATE-16 family has GABARAPL2.
  • LC3B is undoubtedly the most intensive research, and it is considered to be a marker of autophagy. There have been no reports on modulators of LC3B, and the development of modulators of LC3B is urgent for the treatment of related diseases.
  • the present invention provides a compound of the formula 1 or a pharmaceutically acceptable salt thereof -
  • X and Y are each independently selected from the group consisting of 0, S, NR a , NOH and CH 2 ;
  • U and V are each independently selected from C, S, SO and POR a ;
  • W, Z and T are each independently selected from the group consisting of 0, S, SO, S0 2 , N, NR a , CO, C, CR a , and CH 2 ;
  • n 0, 1, 2 or 3; preferably 0 or 1;
  • n 0, 1, 2 or 3; preferably 0 or 1;
  • K is a covalent bond, NR a , CRcRe' or CRJ ⁇ CRcRc;
  • M is a covalent bond, a divalent 3-10 membered heterocycloalkyl group, a divalent 3-7 membered heterocycloalkenyl group or a divalent 5-10 membered heteroaryl group;
  • Q is hydrogen, C1-6 alkyl, C1-6 hydroxyalkyl, -(CH 2 ) p -C(0)R b , -(CH 2 ) p -C(0) HR b , -(CH 2 ) p -C(S)R b , -(CH 2 ) p -C(S)NHR b , -(CH 2 ) p -S0 2 R b , -(CH 2 ) p -S0 2 NHR b ,
  • p is 0, 1, 2 or 3; preferably 0 or 1;
  • R e and Rc' is independently selected from the group consisting of hydrogen, hydroxy, amino, RaRa', halogen, cyano, nitro, carboxy, formyl, amide, ester, C1-6 halogenated fluorenyl, C1-6 hydroxy Alkyl, C1-6 heteroalkyl, C1-6 alkoxy, C1-6 alkoxyalkyl, C2-6 alkenyl, C2-6 alkynyl, C6-10 aryl, 5-10 membered heteroaryl Base, C3-10 cycloalkyl, 3-10 membered heterocyclic fluorenyl, 3-7 membered heterocycloalkenyl, C1-6 fluorenyl C6-10 aryl, 5-10 membered heteroaryl C1-6 alkyl Or a C1-6 mercapto 5-10 membered heteroaryl; preferably selected from the group consisting of hydrogen, hydroxy, amino, NRaRa', halogen, carboxy, formyl, amide, ester, C1-6 hal
  • R 3 , R 4 and each independently selected from the group consisting of hydrogen, hydroxy, amino, halogen, cyano, nitro, carboxy, formyl, amide, -NH-COR b , ester, C1-6 fluorenyl, C1-6 Haloalkyl, C1-6 hydroxydecyl, C1-6 heteroalkyl, C1-6 decyloxy, C1-6 alkoxyfluorenyl, C2-6 alkenyl, C2-6 alkynyl, unsubstituted or substituted -CONH-(C6-10 aryl), unsubstituted or substituted -CH CH-(C6-10 aryl;), unsubstituted or substituted C6-10 aryl, unsubstituted or substituted 5-10 member Heteroaryl, unsubstituted or substituted C3-10 cyclodecyl, unsubstituted or substituted 3-10 membered heterocyclic fluorenyl, unsubstituted or
  • R 3 , R 4 and R 5 may be bonded to form an unsubstituted or substituted C 6-10 aryl group, an unsubstituted or substituted 5-10 membered heteroaryl group, an unsubstituted or substituted C 3 3 10 fluorenyl or unsubstituted or substituted 3-10 membered heterocycloalkyl; wherein each R b is independently C 1-6 alkyl, C 2-6 alkenyl, NHR a , R a R a ', unsubstituted Or substituted phenyl or 3-7 membered heterocyclic group;
  • R a and R a ' is independently hydrogen or C1-6 fluorenyl
  • Unsubstituted or substituted means that the group is unsubstituted or substituted by one or more substituents selected from the group consisting of hydroxy, amino, cyano, nitro, carboxy, halogen, C1-6 fluorenyl, C 1- 6 halodecyl or C 1-6 hydroxyalkyl, or two adjacent substituents may be bonded to form a C6-10 aryl group, a C5-10 heteroaryl group, a C3-10 cycloalkyl group or a C3-10 heterocycloalkane Base
  • X and Y are each independently selected from 0, S or H;
  • U and V are each independently selected from C or S;
  • W, Z and T are each independently selected from the group consisting of 0, N, R a , CO, C, CR a , and CH 2 ;
  • n is. , 1 or 2;
  • n 0, 1 or 2;
  • K is a covalent bond, NR a , CR e R e , or CReRc RcRc,;
  • M is a covalent bond, CH, a divalent 3-10 membered heterocycloalkyl group, a divalent 3-7 membered heterocycloalkenyl group or a divalent 5-10 membered heteroaryl group;
  • Q is hydrogen, C1-6 fluorenyl, C1-6 hydroxy fluorenyl, -(CH 2 ) p -C(0)R b , -(CH 2 ) p -C(0) HR b , -(CH 2 ) p -C(S)R b , -(CH 2 ) p -C(S)NHR b , -(CH 2 ) p -S0 2 R b , -(CH 2 ) p -S0 2 NHR b , wherein
  • p is 0, 1, 2 or 3; preferably 0 or 1;
  • R e and Rc' is independently selected from the group consisting of hydrogen, hydroxy, amino, RaRa', halogen, cyano, nitro, carboxy, formyl, amide, ester, C1-6 haloalkyl, C1-6 hydroxyalkyl , C1-6 heteroalkyl, C1-6 alkoxy, C1-6 alkoxyfluorenyl, C2-6 alkenyl, C2-6 alkynyl, C6-10 aryl, 5-10 membered heteroaryl, C3-10 cyclodecyl, 3-10 membered heterocycloalkyl, 3-7 membered heterocycloalkenyl, C1-6 alkyl C6-10 aryl, 5-10 membered heteroaryl C1-6 fluorenyl or C1 -6-mercapto 5-10 membered heteroaryl; preferably selected from the group consisting of hydrogen, hydroxy, amino, NRaRa', halogen, carboxy, formyl, amide, ester, C1-6 halogen,
  • R 3 , R 4 and R 5 may be bonded to form an unsubstituted or substituted C 6-10 aryl group, an unsubstituted or substituted 5-10 membered heteroaryl group, an unsubstituted or substituted C 3 3 10 fluorenyl or unsubstituted or substituted 3-10 membered heterocycloalkyl; wherein each R b is independently C 1-6 alkyl, C 2-6 alkenyl, NHR a , R a R a ', unsubstituted Or substituted phenyl or 3-7 membered heterocyclic group;
  • Each and R a ' is independently hydrogen or C1-6 fluorenyl
  • Unsubstituted or substituted means that the group is unsubstituted or substituted by one or more substituents selected from the group consisting of hydroxy, amino, cyano, nitro, carboxy, halogen, C1-6 alkyl, C 1- 6 haloalkyl and C 1-6 hydroxy fluorenyl, or two adjacent substituents may be bonded to form a C6-10 aryl group, a 5-10 membered heteroaryl group, a C3-10 cycloalkyl group or a 3-10 membered heterocyclic ring Base; and meet the following conditions -
  • R 2 is selected from the following groups: ⁇ ,
  • A is a divalent 3-10 membered nitrogen-containing heterocyclic fluorenyl group or a divalent 3-7 membered nitrogen-containing heterocycloalkenyl group;
  • Rc, Rc' and R c " are each independently selected from the group consisting of hydrogen, hydroxy, amino, NRaRa', halogen, cyano, nitro, carboxy, formyl, amide, ester, C1-6 haloalkyl, C1-6 Hydroxyalkyl, C1-6 heteroalkyl, C1-6 alkoxy, C1-6 alkoxyalkyl, C2-6 alkenyl, C2-6 alkynyl, C6-10 aryl, 5-10 member Aryl, C3-10 cycloalkyl, 3-10 membered heterocycloalkyl, 3-7 membered heterocycloalkenyl, C1-6 fluorenyl C6-10 aryl, 5-10 membered heteroaryl C1-6 alkane Or a C1-6 alkyl 5-10 membered heteroaryl; preferably selected from the group consisting of hydrogen, hydroxy, amino, NRaRa', halogen, carboxy, formyl, amide, ester, C1-6 halogenated flu
  • Each and R a ' is independently hydrogen or C1-6 fluorenyl.
  • Rc, R cl DR c2 is selected from the group consisting of hydrogen, hydroxy, amino, RaRa', halogen, cyano, nitro, carboxy, formyl Base, amide group, ester group, C1-6 hydrazino group, C1-6 hydroxyalkyl group, C1-6 heteroalkyl group, C1-6 decyloxy group, C1-6 alkoxyalkyl group, C2-6 alkenyl group , C2-6 alkynyl, C6-10 aryl, 5-10 membered heteroaryl, C3-10 cyclodecyl, 3-10 membered heterocycloalkyl, 3-7 membered heterocycloalkenyl, C1-6 alkane a C6-10 aryl group, a 5-10 membered heteroaryl C1-6 alkyl group or a C1-6 fluorenyl 5-10 membered heteroaryl group; preferably selected from the group consisting of hydrogen, hydroxy, amino, NRaRa', halogen,
  • Or can be linked to Rc 2 to form a C6-10 aryl group, a 5-10 membered heteroaryl group, a C3-10 cyclodecyl group and a 3-10 membered heterocyclic group;
  • each! ⁇ and R a ' are independently hydrogen or C1-6 fluorenyl.
  • the compound of formula (I) is selected from the group consisting of compounds of formula (la) or (lb) below.
  • X and Y are each independently selected from 0, S or NH;
  • W, Z and T are each independently selected from 0, N, NR a , CO, C, CR a , or CH 2 ;
  • n is. , 1 or 2;
  • n 0, 1 or 2;
  • J is NR a , NOR a , 0, S or, wherein J is a divalent 3-10 membered heterocyclic fluorenyl group containing at least one nitrogen atom or a divalent 3-7 membered heterocycloalkenyl group;
  • M is a covalent bond, a divalent 3-10 membered heterocycloalkyl group, a divalent 3-7 membered heterocycloalkenyl group or a divalent 5-10 membered heteroaryl group;
  • Q is hydrogen, C1-6 alkyl, C1-6 hydroxy fluorenyl, -(CH 2 ) p -C(0)R b , -(CH 2 ) p -C(0)NHR b , -(CH 2 ) p -C(S)R b , -(CH 2 )pC(S)NHR b , -(CH 2 )p-S0 2 R b , -(CH 2 ) p -S0 2 NHR b ,
  • p is 0, 1, 2 or 3; preferably 0 or 1;
  • R 3 , R 4 and R 5 may be bonded to form an unsubstituted or substituted C 6-10 aryl group, an unsubstituted or substituted 5-10 membered heteroaryl group, an unsubstituted or substituted C 3 3 10 fluorenyl or unsubstituted or substituted 3-10 membered heterocyclic fluorenyl; wherein each R b is independently C 1-6 alkyl, C 2-6 alkenyl, NHR a , R a R a ', unsubstituted Or substituted phenyl or 3-7 membered heterocyclic group;
  • Each of ⁇ and R a ' is independently hydrogen or C1-6 fluorenyl
  • Unsubstituted or substituted means that the group is unsubstituted or substituted by one or more substituents selected from the group consisting of hydroxy, amino, cyano, nitro, carboxy, halogen, C1-6, C1- 6 halodecyl and C 1-6 hydroxy fluorenyl, or two adjacent substituents may be bonded to form a C6-10 aryl group, a 5-10 membered heteroaryl group, a C3-10 cycloalkyl group or a 3-10 membered hetero ⁇ ⁇ ; and meet the following conditions:
  • the compound of formula (X) is selected from the group consisting of the following formulae IIa), (lib), (lie) and (lid)
  • X and Y are independently 0, S, NH;
  • W, Z and T are each independently selected from 0, N, R a , CO, C, CR a , or CH 2
  • n 0, 1, 2 or 3;
  • J is selected from the group consisting of Ra, NOR a , 0 and S;
  • K is a covalent bond, NR a , CR e R e , or CReR ⁇ CRcR ⁇ ;
  • Q is hydrogen, Cl-6 fluorenyl, Cl-6 hydroxy fluorenyl, -(CH 2 ) p -C(0)R b , -(CH 2 ) p -C(0) HR b , -(CH 2 ) p -C(S)R b , -(CH 2 ) p -C(S)NHR b , -(CH 2 ) p -S0 2 R b , -(CH 2 ) p -S0 2 NHR b ,
  • p is 0, 1, 2 or 3; preferably 0 or 1;
  • Rc, Rc' and Re are each independently selected from the group consisting of hydrogen, hydroxy, amino, NRaRa', halogen, cyano, nitro, carboxy, formyl, amide, ester, C1-6 haloalkyl, C1-6 hydroxy Alkyl, C1-6 heteroalkyl, C1-6 alkoxy, C1-6 decyloxy, C2-6 alkenyl, C2-6 alkynyl, C6-10 aryl, 5-10 membered heteroaryl Base, C3-10 cyclodecyl, 3-10 membered heterocyclic fluorenyl, 3-7 membered heterocycloalkenyl, C1-6 alkyl C6-10 aryl, 5-10 membered heteroaryl C1-6 alkyl Or a C1-6 alkyl 5-10 membered heteroaryl; preferably selected from the group consisting of hydrogen, hydroxy, amino, NRaRa', halogen, carboxy, formyl, amide, ester, C1-6 haloal
  • R 3 and R 4 are bonded to form an unsubstituted or substituted C 6-10 aryl group, an unsubstituted or substituted 5-10 membered heteroaryl group, an unsubstituted or substituted C 3-10 cyclodecyl group or an unsubstituted or substituted 3- 10-membered heterocyclic fluorenyl;
  • each R b is independently C1-6 fluorenyl, C 2-6 alkenyl, NHR a , R a R a ', unsubstituted or substituted phenyl or 3-7 membered heterocyclic group;
  • Each and Ra' are independently hydrogen or C1-6 fluorenyl
  • Unsubstituted or substituted means that the group is unsubstituted or substituted by one or more substituents selected from the group consisting of hydroxy, amino, cyano, nitro, carboxy, halogen, C1-6 alkyl, C 1- 6 haloalkyl and C 1-6 hydroxy fluorenyl, or two adjacent substituents may be bonded to form a C6-10 aryl group, a 5-10 membered heteroaryl group, a C3-10 cycloalkyl group or a 3-10 membered heterocyclic ring Base; and meet the following conditions -
  • the compound of formula (X) is selected from the group consisting of the following formulae IIIa), (IIIb), (IIIc) and (Hid): Compound : (Ilia), (Illb),
  • 1 is selected from the group consisting of hydrogen, hydrazine, C1-6 fluorenyl, C1-6 hydroxy fluorenyl, C1-6 halogenated fluorenyl, unsubstituted or substituted phenyl; preferably selected from hydrogen and hydrazine; preferably hydrogen;
  • J is selected from NRa, NORa, O or S;
  • Q is hydrogen, C1-6 alkyl, C1-6 hydroxy fluorenyl, -(CH 2 ) p -C(0)R b , -(CH 2 ) p -C(0) HR b , -(CH 2 ) p -C(S)R b , -(CH 2 ) p -C(S)NHR b , -(CH 2 ) p -S0 2 R b , or -(CH 2 ) p -S0 2 HR b ,
  • p is 0, 1, 2 or 3; preferably 0 or 1;
  • Each R e , ! ⁇ And! ⁇ "Independently selected from hydrogen, hydroxy, amino, NRaRa', halogen, cyano, nitro, carboxy, formyl, amide, ester, C1-6 alkyl, C1-6 hydroxyalkyl, C1- 6heteroalkyl, C1-6 alkoxy, C1-6 alkoxyfluorenyl, C2-6 alkenyl, C2-6 alkynyl, C6-10 aryl, 5-10 membered heteroaryl, C3-10 Cyclodecyl, 3-10 membered heterocyclic fluorenyl, 3-7 membered heterocycloalkenyl, C1-6 fluorenyl C6-10 aryl, 5-10 membered heteroaryl C1-6 fluorenyl or C1-6 ⁇ 5-10 membered heteroaryl; preferably selected from the group consisting of hydrogen, hydroxy, amino, NRaRa', halogen, carboxy, formyl, amide, ester, C1-6
  • R 3 are bonded to form an unsubstituted or substituted C6-10 aryl group, an unsubstituted or substituted 5-10 membered heteroaryl group, an unsubstituted or substituted C3-10 cycloalkyl group or an unsubstituted or substituted 3-10 Monocyclic sulfhydryl group;
  • each R b is independently C 1-6 alkyl, C 2-6 alkenyl, HR a , R a R a ', unsubstituted or substituted phenyl or 3-7 membered heterocyclic group;
  • Each and R a ' is independently hydrogen or C1-6 fluorenyl
  • Unsubstituted or substituted means that the group is unsubstituted or substituted by one or more substituents selected from the group consisting of hydroxy, amino, cyano, nitro, carboxy, halogen, C1-6 fluorenyl, C 1 -6 halodecyl and C 1-6 hydroxyalkyl, or two adjacent substituents may be bonded to form a C6-10 aryl group, a 5-10 membered heteroaryl group, a C3-10 cycloalkyl group or a 3-10 member. Heterocyclic fluorenyl.
  • the compound of formula (I) is selected from the group consisting of the following general formulae (IVa), (IVb:), (IVc) and
  • J is NR a , NORa, 0 or S;
  • NR a NR a , CR e R e , or CReRc RcRc,; a divalent 3-10 membered nitrogen-containing heterocycloalkyl group or a divalent 3-7 membered nitrogen-containing heterocycloalkenyl group;
  • Q is hydrogen, C1-6 fluorenyl, C1-6 hydroxy fluorenyl, -(CH 2 ) p -C(0)R b , -(CH 2 ) p -C(0) HR b , -(CH 2 ) p -C(S)R b , -(CH 2 ) P -C(S)NHR b , -(CH 2 ) p -S0 2 R b , -(CH 2 ) P -S0 2 NHR b ,
  • p is 0, 1, 2 or 3; preferably 0 or 1;
  • Rc, Rc' and Rc" are each independently selected from the group consisting of hydrogen, hydroxy, amino, RaRa', halogen, cyano, nitro, carboxy, formyl, amide, ester, C1-6 halogenated fluorenyl, C1 -6 hydroxy fluorenyl, C1-6 heterofluorenyl, C1-6 decyloxy, C1-6 fluorenyl fluorenyl, C2-6 alkenyl, C2-6 alkynyl, C6-10 aryl, 5-10 Monoheteroaryl, C3-10 cyclodecyl, 3-10 membered heterocyclic fluorenyl, 3-7 membered heterocycloalkenyl, C1-6 alkyl C6-10 aryl, 5-10 membered heteroaryl C1- 6 alkyl or C1-6 alkyl 5-10 membered heteroaryl; preferably selected from the group consisting of hydrogen, hydroxy, amino, NRaRa', halogen, carboxy, for
  • each R b is independently C 1-6 alkyl, C 2-6 alkenyl, NHR a , R a R a ', unsubstituted or substituted phenyl or 3-7 membered heterocyclic;
  • Each and R a ' is independently hydrogen or C 1-6 alkyl
  • Unsubstituted or substituted means that the group is unsubstituted or substituted by one or more substituents selected from the group consisting of hydroxy, amino, cyano, nitro, carboxy, halogen, C1-6 alkyl, C 1- 6 haloalkyl and C 1-6 hydroxy fluorenyl, or two adjacent substituents may be bonded to form a C6-10 aryl group, a 5-10 membered heteroaryl group, a C3-10 cyclodecyl group or a 3-10 membered heterocyclic ring.
  • substituents selected from the group consisting of hydroxy, amino, cyano, nitro, carboxy, halogen, C1-6 alkyl, C 1- 6 haloalkyl and C 1-6 hydroxy fluorenyl, or two adjacent substituents may be bonded to form a C6-10 aryl group, a 5-10 membered heteroaryl group, a C3-10 cyclodecyl group or a 3-10
  • R4 is selected from the group consisting of hydrogen, hydroxy and C1-6 fluorenyl.
  • each Rc, R el , R c2 , Rc' and Re are independently selected from the group consisting of hydrogen, hydroxy, amino, NRaRa', halogen, cyano, nitro, carboxy, formyl, amide, ester, C1- 6 haloalkyl, C1-6 hydroxyalkyl, C1-6 heterofluorenyl, C1-6 decyloxy, C1-6 decyloxyalkyl, C2-6 alkenyl, C2-6 alkynyl, C6-10 aryl Base, 5-10 membered heteroaryl, C3-10 cycloalkyl, 3-10 membered heterocyclic fluorenyl, 3-7 membered heterocycloalkenyl, C1-6 fluorenyl C6-10 aryl, 5-10.
  • Heteroaryl C1-6 fluorenyl or C1-6 fluorenyl 5-10 membered heteroaryl preferably selected from the group consisting of hydrogen, hydroxy, amino, RaRa', halogen, carboxy, formyl, amide, ester, C1-6 Haloalkyl, C1-6 hydroxyalkyl, C1-6 heterofluorenyl, C1-6 decyloxy, C3-10 cyclononyl, 3-10 membered heterocycloalkyl, substituted or unsubstituted phenyl or pyridyl ;
  • Each of R and R a ' is independently hydrogen or C1-6 alkyl.
  • X 1 is F, Cl, Br, I or a trifluoromethyl group
  • X 2 is H, F, Cl, Br or I
  • Rci, Rc3 or R. 4 each independently selected from the group consisting of hydrogen, hydroxy, amino, NRaRa', halogen, cyano, nitro, carboxy, formyl, amide, ester, C1-6 halogenated fluorenyl, C1-6 hydroxyalkyl, C1 -6 heteroalkyl, C1-6 alkoxy, C1-6 alkoxyalkyl, C2-6 alkenyl, C2-6 alkynyl, C6-10 aryl, 5-10 membered heteroaryl, C3- 10 cycloalkyl, 3-10 membered heterocyclic fluorenyl, 3-7 membered heterocycloalkenyl, C1-6 alkyl C6-10 aryl, 5-10 membered heteroaryl C1-6 fluorenyl or C1-6 Alkyl 5-10 membered heteroaryl; preferably selected from the group consisting of hydrogen, hydroxy, amino, NRaRa', halogen, carboxy, formyl, amide, ester
  • Rc3 and Rc 4 may be bonded to form a C6-10 aryl group, a 5-10 membered heteroaryl group, a C3-10 cyclodecyl group and a 3-10 membered heterocyclic ring. ⁇ ;
  • Each of R and R a ' is independently hydrogen or C1-6 alkyl.
  • R 4 and in the formula (I) are hydrogen.
  • the compound of formula (I) is selected from the group consisting of the following formula (Va), (Vb) and (Vc):
  • W is selected from the group consisting of: 0, NRa and CHR a ;
  • J is NR a , NORa, O or S;
  • K is a covalent bond, NR a , CH' or CR e Rc, CR c Rc,;
  • Ring A is a divalent 3-10 membered nitrogen-containing heterocyclic fluorenyl group or a divalent 3-7 membered nitrogen-containing heterocycloalkenyl group;
  • the B ring is an unsubstituted or substituted C6-10 aryl group or a 5-10 membered heteroaryl group; preferably, the B ring is an unsubstituted or substituted C6-10 aryl group, more preferably the B ring is an unsubstituted or substituted benzene group.
  • Rc, Rc, and! Each independently selected from the group consisting of hydrogen, hydroxy, amino, NRaRa', halogen, cyano, nitro, carboxy, formyl, amide, ester, C1-6 haloalkyl, C1-6 hydroxyalkyl, C1-6 Heteroalkyl, C1-6 alkoxy, C1-6 ⁇ oxyalkyl, C2-6 alkenyl, C2-6 alkynyl, C6-10 aryl, 5-10 membered heteroaryl, C3-10 ring Mercapto, 3-10 membered heterocyclic fluorenyl, 3-7 membered heterocycloalkenyl, C1-6 alkyl C6-10 aryl, 5-10 membered heteroaryl C1-6 alkyl or C1-6 alkyl 5-10 membered heteroaryl; preferably selected from the group consisting of hydrogen, hydroxy, amino, NRaRa', halogen, carboxyl, formyl, amide, ester, C1-6 haloalkyl
  • Each R a is independently selected from the group consisting of hydrogen and C 1 -6 fluorenyl.
  • the compound of the invention or a pharmaceutically acceptable salt thereof is preferably selected from the following compounds or salts:
  • the invention provides a pharmaceutical composition comprising a compound according to the invention or a pharmaceutically acceptable salt thereof.
  • the pharmaceutical composition may also comprise a pharmaceutical excipient.
  • the invention provides the use of a compound according to the invention, or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for modulating autophagy in a cell.
  • the agent that modulates autophagy is a drug that modulates a mammalian ATG8 homolog.
  • the agent for modulating autophagy is a medicament for preventing or treating a disease associated with autophagy, particularly a mammalian ATG8 homolog.
  • the invention provides a method of modulating autophagy in a subject comprising administering a compound according to the invention, or a pharmaceutically acceptable salt thereof, to a subject in need thereof.
  • the method of modulating autophagy is a method of modulating a mammalian ATG8 homolog.
  • the method of modulating autophagy is a method of preventing or treating a disease associated with autophagy, particularly a mammalian ATG8 homolog.
  • the mammalian ATG8 homolog is LC3B.
  • the prevention or treatment of a disease associated with autophagy is selected from the group consisting of a tumor, a cardiovascular disease, an autoimmune disease, Degenerative diseases, hypertension, bone tissue and bone diseases, Crohn's disease, acute kidney injury, cerebral ischemia, retinal disease, bronchial asthma, Vici syndrome, and infectious diseases.
  • the tumor is selected from the group consisting of liver cancer, lung cancer, pancreatic cancer, breast cancer, cervical cancer, endometrial cancer, colorectal cancer, gastric cancer, lung cancer, nasopharyngeal cancer, ovarian cancer, prostate cancer , leukemia, lymphoma, myeloma.
  • some preferred compounds are selected from the group consisting of a compound of the formula Ob), a compound of the formula end), a compound of the formula and; ClVd) compound, and formula
  • C1-6 alkyl refers to "C1-6 fluorenyl” and "C1-6 hydroxy fluorenyl”, “C1-6 halogenated fluorenyl”, “C6-10 aryl C1-6 alkane”
  • C1-6 fluorenyl moiety such as “C1-6 alkyl C6-10 aryl", “C1-6 methoxy”, and the like.
  • “Pharmaceutical composition” means a composition suitable for administration to a patient.
  • the composition may contain only a compound of the invention or a mixture containing a compound of the invention, or a salt, solvate, prodrug, isomer or tautomer of the compound of the invention, or may contain one or A compound of the invention in combination with a plurality of pharmaceutically acceptable carriers or adjuvants.
  • "Patient” includes both human and non-human animals.
  • the pharmaceutical composition may be in various forms such as tablets, capsules, powders, syrups, solutions, suspensions and aerosols, and the like, and may be present in a suitable solid or liquid carrier or diluent and suitable for use In the sterilizing device for injection or drip.
  • the compound dosage form comprises from 0.05 to 200 mg of the compound of the formula (I), preferably, the unit dosage of the formulation comprises from 0.1 mg to 100 mg of the compound of the formula (I).
  • the compounds and pharmaceutical compositions of the invention can be used clinically in mammals, including humans and animals, through the mouth, nose, Route of administration for the skin, lungs, or gastrointestinal tract, and the like. Most preferably oral.
  • the best preferred daily dose is 0.01 - 200 mg / kg body weight, taken once, or 0.01-100 mg / kg body weight.
  • the optimal dosage for the individual should be based on the particular treatment. Usually starting with a small dose, gradually increasing the dose until the most suitable agent is found
  • Halogen (or halo) means fluoro, chloro, bromo or iodo.
  • C1-6 fluorenyl group means a straight-chain or branched alkyl group having 1 to 6 carbon atoms, preferably a linear or branched fluorenyl group having 1 to 4 carbon atoms. Branched means that one or more mercapto groups of 1 to 4 carbon atoms such as a methyl group, an ethyl group or a propyl group are bonded to a linear alkyl group.
  • Preferred C1-6 thiol groups include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, and t-butyl groups.
  • C1-6 haloalkyl means a C1-6 fluorenyl group as defined above containing one or more substituents of a halogen atom.
  • C2-6 alkenyl group means a linear or branched alkenyl group having 2 to 6 carbon atoms, preferably 2 to 4 carbon atoms. Branched means that one or more lower C1-6 thiol groups are attached to a linear C2-6 alkenyl chain.
  • Preferred C2-6 alkenyl groups include, but are not limited to, ethenyl, propenyl, n-butenyl, 3-methylbutenyl, n-pentenyl and the like.
  • C1-6 anthracene group means a divalent group obtained by removing one hydrogen atom from the C1-6 alkyl group defined above.
  • Preferred C1-6 alkylene groups include, but are not limited to, methylene, ethylene, propylene, and the like. In general, it may equally be optionally and denoted herein as - (alkyl with a C1-6) -, for example, -CH 2 CH 2 - is ethylene.
  • C2-6 alkynyl group means a straight or branched alkynyl group having 2 to 6 carbon atoms, preferably 2 to 6 carbon atoms, more preferably 2 to 4 carbon atoms. Branched means that one or more thiol groups having 2 to 4 carbon atoms are attached to the linear alkynyl chain.
  • Preferred C2-6 alkynyl groups include, but are not limited to, ethynyl, propynyl, 2-butynyl, 3-methylbutynyl and the like.
  • substituted C2-6 alkenyl group means a difunctional group obtained by removing one hydrogen atom from the C2-6 alkenyl group defined above.
  • C6-10 aryl means an aromatic monocyclic or polycyclic ring system containing from 6 to 10 carbon atoms.
  • Preferred C6-10 aryl groups include, but are not limited to, phenyl and naphthyl.
  • C6-10 arylene means a divalent group obtained by removing one hydrogen atom from the C6-10 aryl group defined above, for example
  • 5-10 membered heteroaryl means an aromatic monocyclic or polycyclic group having 5 to 10 ring atoms, and the 5-10 membered heteroaryl group includes 1 to 4 of N, 0 and S. A hetero atom.
  • Preferred 5-10 membered heteroaryl groups contain 5 to 6 ring atoms.
  • the nitrogen atom of the 5-10 membered heteroaryl group can be optionally oxidized to the corresponding N-oxide.
  • the term "5-10 membered heteroaryl” also includes a C6-10 aryl fused ring as defined above.
  • Preferred 5-10 membered heteroaryl groups include, but are not limited to, pyridinyl, pyrazinyl, furyl, thienyl, pyrimidinyl, pyridone, oxazolyl, isothiazolyl, oxazolyl, oxadiazolyl, thiazole Base, thiadiazolyl, pyrazolyl, furazanyl, pyrrolyl, triazolyl, 1,2,4-thiadiazolyl, pyridazinyl, quinoxalinyl, pyridazinyl, Hydroxamyl, imidazo[l,2-a]pyridyl, imidazo[2,1-b]thiazolyl, benzofurazanyl, fluorenyl, azaindole, benzo Imidazolyl, benzothienyl, quinolyl, imidazolyl, thienopyridyl, quinazolinyl
  • C3-10 cycloalkyl group means a non-aromatic monocyclic or polycyclic group having 3 to 10 carbon atoms, preferably 3 to 6 carbon atoms.
  • Preferred monocyclic C3-10 cyclodecyl groups include, but are not limited to, cyclopropyl, cyclopentyl, cyclohexyl, cycloheptyl and the like.
  • Preferred polycyclic fluorenyl groups include, but are not limited to, [1 ⁇ 1]-dicyclopentamethylene, 1-decanoyl, norbornyl, adamantyl and the like.
  • C3-10 cycloalkenyl means a non-aromatic monocyclic or polycyclic group containing from 3 to 10 carbon atoms which contains at least one intra-carbon-carbon double bond, preferably from 3 to 7 ring atoms, More preferably, it contains 5 to 7 ring atoms.
  • the C3-10 cycloalkenyl group includes, but is not limited to, a cyclopropenyl group, a cyclobutenyl group, a cyclopentenyl group, a cyclohexenyl group, a cyclopentenyl group, a cycloheptanium-1,3-dienyl group, Norbornyl and the like.
  • the "3-10 membered heterocyclic fluorenyl group” (or “3-10 membered heterocyclic group”) means a non-aryl group having 3 to 10 ring atoms, preferably 5 to 10 ring atoms, preferably 5 to 6 ring atoms. a saturated monocyclic or polycyclic group, wherein the 3-10 membered heterocyclic group contains 1 to 4 hetero atoms selected from N, 0 and S, and the two heteroatoms in the ring system do not adjacent.
  • the nitrogen or sulfur atom of the 3-10 membered heterocyclic group can be optionally oxidized to the corresponding N-oxide, S-oxide or S,S-dioxide.
  • oxide refers to the corresponding N-oxide, S-oxide or S,S-dioxide.
  • Preferred monocyclic 3-10 membered heterocyclic fluorenyl groups include, but are not limited to, piperidinyl, oxetanyl, pyrrolyl, piperazinyl, morpholinyl, thiomorpholinyl, thiazolidinyl, 1,4- Dioxo C1-6 fluorenyl, tetrahydrofuranyl, tetrahydrothiophenyl, lactam (eg pyrrolidinyl;), lactone groups of 3 to 10 ring atoms and oxides thereof.
  • the "3-7 membered heterocycloalkenyl group” means a non-aromatic monocyclic or polycyclic group having 3 to 7 ring atoms, preferably 5 to 6 ring atoms, wherein the 3-7 membered heterocyclic alkene
  • the group contains 1 to 4 hetero atoms selected from N, 0 and S, and it contains at least one carbon-carbon double bond or carbon-nitrogen double bond. There are no adjacent oxygen and/or sulfur atoms present in the ring system.
  • the prefix aza, oxa or thia before the 3-7 membered heterocycloalkenyl name means that at least one nitrogen, oxygen or sulfur atom respectively acts as a ring atom.
  • the nitrogen or sulfur atom of the 3-7 membered heterocycloalkenyl can be optionally oxidized to the corresponding N-oxide, S-oxide or 8, S-dioxide.
  • Preferred 3-7 membered heterocycloalkenyl groups include, but are not limited to, 1,2,3,4-tetrahydropyridyl, 1,2-dihydropyridyl, 1,4-dihydropyridyl, 1,2,3 ,6-tetrahydropyridyl, 1,4,5,6-tetrahydropyrimidinyl, 2-pyrroline, 3-pyrroline, 2-imidazolinyl, 2-pyrazolyl, dihydroimidazolyl And a dihydrooxazolyl group, a dihydrooxadiazolyl group, a dihydrothiazolyl group, a 3,4-dihydro-2H-pyranyl group, a dihydrofuranyl group, a fluorodihydro
  • C6-10 aryl C1-6 fluorenyl (or “C6-10 aryl C1-6 alkyl”) means a group formed by linking a C6-10 aryl group and a C1-6 fluorenyl group as defined above.
  • Preferred C6-10 aryl C1-6 alkyl groups include, but are not limited to, benzyl, 2-phenethyl and naphthylmethyl.
  • the C6-10 aryl C1-6 fluorenyl group is bonded to the parent moiety through a C1-6 alkyl group.
  • C1-6 Mercapto C6-10 aryl means a group formed by linking a C1-6 alkyl group as defined above and a C6-10 aryl group.
  • Preferred C1-6 alkyl C6-10 aryl groups include, but are not limited to, tolyl.
  • the C1-6 alkyl C6-10 aryl group is bonded to the parent moiety through a C6-10 aryl group.
  • the "5-10 membered heteroaryl C1-6 fluorenyl group” means a group formed by linking a 5-10 membered heteroaryl group as defined above and a C1-6 fluorenyl group.
  • Preferred C6-10 aryl C1-6 alkyl groups include, but are not limited to, pyridylmethyl and quinolin-3-ylmethyl.
  • the 5-10 membered heteroaryl C1-6 fluorenyl group is bonded to the parent moiety through a C1-6 fluorenyl group.
  • C1-6 hydroxy fluorenyl group means a C1-6 fluorenyl group substituted by a hydroxy group, wherein the C1-6 fluorenyl group is as described above.
  • Preferred C1-6 hydroxy fluorenyl groups include, but are not limited to, hydroxymethyl and 2-hydroxyethyl.
  • C1-6 methoxy means a C1-6 fluorenyl-0- group bonded to the parent moiety through oxygen, wherein the C1-6 alkyl group is as defined above.
  • Preferred C1-6 alkoxy groups include, but are not limited to, methoxy, ethoxy, n-propoxy, isopropoxy and n-butoxy.
  • C1-6 alkoxyalkyl group means a group derived from a C1-6 methoxy group and a C1-6 fluorenyl group as defined in the present invention, and is bonded to the parent moiety through a C1-6 alkyl group.
  • Ester group means -C(0)ORx, which is C1-6 mercapto, C6-10 aryl, C6-10 aryl C1-6 alkyl and C3-10 cycloalkyl.
  • Preferred ester groups include, but are not limited to, methyl ester groups, ethyl ester groups, isopropyl ester groups, tert-butyl ester groups, phenyl ester groups.
  • “Amido” means -C(0) R y R y , wherein R y and R y are hydrogen, C 1 -6 fluorenyl, C 6-10 aryl, C 6-10 aryl C 1-6 alkyl Or C3-10 cycloalkyl.
  • any of the foregoing functional groups of the present invention may be unsubstituted or substituted with a substituent as described herein.
  • substituted refers to the replacement of one or more hydrogen atoms on a given atom with a group selected from a specified group, provided that the normal valence of the specified atom is not exceeded and that the substitution results in a stable Compound.
  • the combination of substituents and/or variables is permissible only when the combination forms a stabilizing compound; "stable compound” or “stable structure” means having the ability to be separated from the reaction mixture to a useful purity and configured to be effective A compound with sufficient stability for a therapeutic agent.
  • unsubstituted or substituted means that a particular group is unsubstituted or substituted with one or more substituents.
  • the substituent includes, without limitation, hydrogen, hydroxy, amino, cyano, nitro, carboxy, halogen, C1-6 alkyl, C1-6 haloalkyl or C1-6 hydroxyindenyl. Two adjacent substituents may be bonded to form a C6-10 aryl group, a 5-10 membered heteroaryl group, a C3-10 cyclodecyl group or a 3-10 membered heterocyclic fluorenyl group.
  • a tautomer refers to a compound produced by the phenomenon that a proton of one atom in a molecule is transferred to another atom. Tautomers also mean that two or more are readily converted from one isomeric form to another. The isomeric form of the state.
  • One of ordinary skill in the art will recognize the possibility of all tautomeric ring atom arrangements. All such isomeric forms of these compounds are expressly included in the present disclosure.
  • the compounds of the invention include all tautomers thereof, such as keto-enol tautomers.
  • these tautomers and mixtures thereof are partially structured (Example 11,
  • a stereoisomer refers to an isomer of a compound having the same molecular formula and having the same atomic bonding order but different spatial arrangement in the molecule.
  • Enantiomers are stereoisomers that are mirror images of each other; diastereomers refer to molecules having two or more centers of chirality and intermolecular non-mirrored relationship Stereoisomers. Unless otherwise indicated, the specification is intended to include individual stereoisomers and mixtures thereof.
  • the compounds of the invention include all isomers thereof, such as diastereomers and cis/trans (Z/E) isomers.
  • cis-trans isomers of compound 101 disclosed herein are shown below .
  • the compounds of the invention may form metal chelates with one or more metal ions.
  • Metal ions include, but are not limited to, copper, iron, magnesium, calcium, zinc, nickel, and platinum.
  • An example of a metal chelate compound is given in Example 38 as described herein. It should be noted that the compounds of the invention include all metal chelates.
  • pharmaceutically acceptable salts refers to substances which are suitable for use in humans and/or animals without excessive adverse side effects (e.g., toxicity, irritation, and allergic reactions), i.e., having a reasonable benefit/risk ratio.
  • Pharmaceutically acceptable salts include inorganic and organic salts which may be obtained during the final isolation and purification of the compounds of the invention or by the reaction of the free acid or base function with a suitable base or acid.
  • Acids suitable for salt formation include, but are not limited to, inorganic acids such as hydrochloric acid, phosphoric acid or sulfuric acid, or organic acids such as capric acid, ascorbic acid, citric acid, tartaric acid, lactic acid, maleic acid, malonic acid, fumaric acid, glycolic acid.
  • Bases suitable for the formation of salts include, but are not limited to, inorganic bases such as sodium carbonate, sodium hydroxide, potassium carbonate, potassium hydroxide, lithium hydroxide, calcium acetate, calcium chloride or magnesium chloride, and the like, and organic bases such as aminoethanol and the like.
  • an effective amount means that the amount of the compound of the invention contained in the composition to be administered is sufficient to modulate (e.g., inhibit or agonize, etc.;) a mammalian ATG8 homolog.
  • the compounds of the present invention can be prepared by various methods known in the art which are known in the art, and the following reaction schemes are optional for the preparation of the compounds of the present invention.
  • Mass spectrometry was recorded by liquid chromatography-mass spectrometry (LC-MS) (Agilent 6120B single quadrupole liquid chromatography-mass spectrometer). Nuclear magnetic resonance spectroscopy (such as hydrogen spectrum ( , carbon spectrum ( 13 C), phosphorus spectrum ( 31 P) and fluorine spectrum ( 19 F)) using Bruker AMX-400, Gemini-300 or A X-600 NMR Recorded in deuterated solvents such as deuterated chloroform, deuterated methanol, deuterated water or deuterated dimethyl sulfoxide and referenced to deuterated solvent peaks.
  • deuterated solvents such as deuterated chloroform, deuterated methanol, deuterated water or deuterated dimethyl sulfoxide and referenced to deuterated solvent peaks.
  • the unit of chemical shift ⁇ is ppm
  • coupling constant (J or The unit of J) is Hertz Hz, Hertz)
  • the coupling split peaks in the nuclear magnetic spectrum are expressed as: wide single peak (brs), single peak;), doublet (d), double doublet (dd), triplet (t), quartet (q) and multiplet (m).
  • Step 1 Synthesis of the compound 2-(2-(4-(2-hydroxyethyl)piperazine-1-yl)ethyl)isoindoline-1,3-dione
  • Step 2 Synthesis of the compound 2-(4-(2-Aminoethyl;) piperazine-]-yl)ethan-1-ol
  • Example 2 Compound 5-(((2-(4-(2-hydroxyethyl))piperazin-1-yl)ethyl)amino)methylene)-2,2-dimethyl-1, 3-dioxin-4,6-dione (compound)
  • Example 3 Synthesis of Compound 2-(Aminomethylene)-5-phenylcyclohexane-1,3-dione (Compound 2) Correction Page (Rule 91) ISA/CN
  • the compound 2-dimethylaminomethylene-5-phenylcyclohexane-1,3-dione (1.1 g, 4.52 mmol) was dissolved in aqueous methanol (7 N, 50 mL).
  • the compound 2-((dimethylamino)methylene)-5-phenylcyclohexane-1,3-dione (200 mg, 0.823 mmol) was dissolved in 5 mL absolute ethanol and 5 mL DCM. ImL acetic acid and sodium thiomethoxide (115 mg, 1.64 mmol), and the mixture was stirred at room temperature for 16 hr. Additional 1 mL of acetic acid and sodium thiomethoxide (115 mg, 1.64 mmol) were added and stirring was continued for 16 hours. After the reaction was completed, the reaction solution was poured into water and extracted with dichloromethane (DCM).
  • DCM dichloromethane
  • Example 8 Compound 2-(((2-(4-(2-hydroxyethyl)piperazin-1-yl)ethyl)amino)methylene)-5-phenylcyclohexane-1 3- Synthesis of diketone (compound 8)
  • Step 1 Synthesis of the compound 2-((Dimethylamino)methylene)-5-phenylcyclohexane-1 3-dione
  • Step 2 Compound 2-(((2-(4-(2-hydroxyethyl)piperazin-1-yl)ethyl)amino)methylene)-5-phenylcyclohexanium-1,3- Diketone
  • the compounds 9-12 and 14-15 are synthesized in the same manner as the compound 8, as shown in Table 2. Shown.
  • Example 9-1 Intermediate 3-1: (2S, 2'R)-7-chloro-4,6-dimethoxy-2'-methyl-3H-spiro [benzofuran-2,1 '-cyclohexane] 3,4-',6'-trione
  • Example 10 Compound 2-(((2-(4-(2-hydroxyethyl)piperazin-1-yl)ethyl)amino)methylene)-5-(1 ⁇ -pyrrolo[2, - Synthesis of b]pyridin-4-yl)cyclohexanyl-1,3-dione (compound 17)
  • Step 1 Synthesis of the compound 4-bromo-1-(phenylsulfonyl >1H-pyrrolo[2,3-b]pyridine
  • Step 2 Synthesis of the compound 1 - (phenylsulfonyl)-4-ethyl C2-6 alkenyl-1 H-pyrrolo[2,3-b]pyridine
  • Step 3 Synthesis of the compound 1 - (phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine-4-carbaldehyde
  • Step 4 Synthesis of the compound 4-(1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)but-3-en-2-one 91) ISA/CN
  • Compound 1-(;phenylsulfonyl;)-1H-pyrrolo[2,3-b]pyridine-4-carbaldehyde (1.52 g, 5.3 mmol) and 1-triphenylphosphino-2-propanone (2.55 g) 8 mmol) was separately added to 30 mL of anhydrous THF, and the reaction was refluxed for 2 hours. After the reaction was completed, the mixture was concentrated to dryness.
  • Step 5 Synthesis of the compound 5-(1 ⁇ -pyrrolo[2,3-b]pyridin-4-yl)cyclohexanyl-1,3-dione
  • Step 6 Compound 2-(((2-(4-(2-hydroxyethyl))piperazin-1-yl)ethyl)amino)methylene)-5-(1 ⁇ -pyrrolo[2,3 , b] pyridin-4-yl;) synthesis of cyclohexene-1,3-dione
  • Step 1 Compound ((3aR, 4R, 6R, 6aR)-2,2-dimethyl-6-(6-morpholino-9H-indol-9-yl)tetrahydrofuro[3,4-d] [ 1,3]dioxo-4-yl;) Synthesis of methanol
  • 6-chloropurine nucleoside (3.0 g, 10.46 mmol), 2,2-dimethoxypropionamidine (5.2 g, 50 mmol) and p-toluenesulfonic acid monohydrate (1.99 g, 10.46 mmol) in acetone (120 ml)
  • acetone 120 ml
  • Step 2 Compound ((3aR, 4R, 6R, 6aR)-2,2-dimethyl-6-(6-morpholino-9H-indol-9-yl)tetrahydrofuro[3,4-d] [ Synthesis of 1,3]dioxo-4-yl)methanol
  • Step 3 Compound (3aS, 4S, 6R, 6aR)-2,2-dimethyl-6-(6-morpholino-9H-indol-9-yl)tetrahydrofuro[3,4-d] [1 Synthesis of 3,dioxol-4-carbaldehyde
  • Example 12 Compound 5-(4-(9H-indol-6-yl)phenyl)-2-(((2-(4-(2-hydroxyethyl)piperazin-1-yl)ethyl)) Synthesis of Amino)methylene)-1,3-Dione (Compound 33)
  • Step 1 Synthesis of the compound 6-chloro-9-(tetrahydro-2H-pyran-2-yl)-9H-indole
  • Step 2 Synthesis of the compound 4-(9-(tetrahydro-2H-pyran-2-yl)-9H-indol-6-yl)benzaldehyde
  • 6-Chloro-9-(tetrahydro-2H-pyran-2-yl)-9H-indole (5.7 g, 24 mmol) sodium carbonate (5.3 g, 50 mmol)
  • 4- aldehyde phenylboronic acid (7.5 g, 50 mmol)
  • tetrakis(triphenylphosphine)palladium (690 mg, 0.6 mmol) was dissolved in a mixed solution of dioxane (200 mL) and water (20 mL) and refluxed overnight. After completion of the reaction, the mixture was cooled to room temperature, poured into ice water, extracted with EtOAc, EtOAc evaporated.
  • Steps 3, 4, and 5 The same steps as in Embodiment 9
  • Step 6 Compound 5-(4-(9H-indol-6-yl)phenyl)-2-(((2-(4-(2-hydroxyethyl)piperazin-1-yl)ethyl)amino) Synthesis of methylene)cyclohexane-1,3-dione
  • Example 12A Compound 2-(((2-(4-(2-hydroxyethyl)piperazinyl)ethyl)amino)methylene)-5-(3-(2-(2-methoxy) Ethoxy)ethoxy)phenyl)cyclohexanyl-1,3-dione (compound 34) o
  • Step 1 Synthesis of the compound 3-(2-(2-methoxyethoxy)ethoxy)benzaldehyde
  • Step 2 Synthesis of the compound 4-(3-(2-(2-methoxyethoxy)ethoxy)phenyl)but-3-en-2-one
  • Steps 3, 4 and 5 Compound 2-(((2-(4-(2-hydroxyethyl)piperazinyl)ethyl)amino)methylene)-5-(3-(2-(2-) Synthesis of methoxyethoxy)ethoxy)phenyl)cyclohexane-1,3-dione
  • Steps 3, 4 and 5 The operation steps are the same as those in the embodiment 9.
  • the compound 35-84 is synthesized in the same manner as the compound 34, as shown in Table 4. .
  • Methyl 1-adamantanecarboxylate (3 g, 15.5 mml) was dissolved in 80 ml of toluene under nitrogen, cooled to -78 ° C, and diisobutylaluminum hydride (1.5 M in toluene, 10.3 mL;) was added dropwise. The mixture was allowed to react to room temperature for 1 hour. The reaction was quenched by dropwise addition of 4N hydrochloric acid, poured into ice water and extracted with EA. The combined organic phases were washed with brine, dried and evaporated. The crude product was isolated by column chromatography to give the title compound 2. lg, yield 82%.
  • 5-bromo-2-thiophenecarboxaldehyde (3.80 g, 20.0 mmol).
  • 4-pyridineboronic acid (3.0 g, 24.0 mmol) > sodium carbonate (3.18 g, 30.0 mmol)
  • palladium acetate 224.0 mg, l .Ommol
  • triphenylphosphine 520.0 mg, 2.0 mmol
  • the reaction mixture was cooled to room temperature and poured into ice water, EtOAc was evaporated, and then evaporated.
  • Step 1 Synthesis of the compound (4-methylbenzo[d]thiazol-2-yl)carbamic acid tert-butyl ester
  • Step 2 Synthesis of the compound (4-(Dibromomethyl)benzo[d]thiazol-2-yl)carbamic acid tert-butyl ester.
  • Correction page (Rule 91) ISA/CN (4-Methylbenzo[d]thiazol-2-yl)carbamic acid tert-butyl ester e (5.2 g, 14.3 mmol), NBS (5.08 g, 28.5 mmol) and AIBN (330 mg, 2 mmol) were dissolved in tetrachloro In 30 mL of carbon, the reaction was refluxed overnight. After completion of the reaction, the reaction mixture was poured into EtOAc EtOAc EtOAc.
  • Step 3 Synthesis of the compound (4-formylbenzo[d]thiazol-2-yl)carbamic acid tert-butyl ester
  • 6-Chloro-9H-indole (1.54 g, 10 mmol), copper acetate (3.63 g, 20 mmol), 4-(hydroxymethyl)benzeneboronic acid (3.63 g, 20 mmol), 1,10-phenanthroline ( 3.60 g, 20 mmol) and 4A molecular sieves (1.0 g) were placed in dry DMF (50 mL) and allowed to react overnight at 40 °C. After the reaction was completed, it was poured into ice water, extracted with EA, and the organic phase was washed with water, dried over sodium sulfate and evaporated. The crude product was purified by column chromatography to yield the title compound 1.49 g, yield 57%.
  • Step 3 Synthesis of the compound 4-(4-(6-ethoxy-9H-indol-9-yl)phenyl)but-3-en-2-one
  • Example 15 Compound 7-(((2-(4-(2-hydroxyethyl))piperazinyl)ethyl)amino)methylene)-spiro[3.5]decane-6,8-dione (chemical
  • Step 1 Synthesis of the compound 2-cyclobutylene ethyl acetate
  • Step 2 Synthesis of the compound snail [3.5] ⁇ -6,8-dione
  • Step 3 Compound 7-(((2-(4-(2-hydroxyethyl)piperazin-1-yl)ethyl)amino)methylene)spiro[3.5]decane-6,8-dione Synthesis
  • the compound 87-94 was synthesized in the same manner as the compound 86, as shown in Table 5.
  • Step 1 Synthesis of the compound 4- «4-bromophenyl;)sulfonyl)morpholine
  • Step 2 Synthesis of the compound 3-(4-(morpholinosulfonyl)phenyl) acrylate
  • 6-(2-Hydroxyethoxy)nicotinyl (4 g, 24 mmol) and TEA (4 mL) were added to DCM (90 mL), m.sub. The solution was stirred at this temperature for 30 minutes and the reaction was completed. The reaction solution was poured into water and extracted with EA. The combined organic layers were dried with anhydrous sodium sulfate and evaporated.
  • Example 17 Compound 3-(((2-(4-(2-hydroxyethyl)piperazine-]-yl)ethyl)amino)methylene)-6-phenyldihydro-2H-pyran -2,4(3H)-
  • Step 1 Preparation of the compound 6-phenyldihydro-2H-pyran-2,4(3H)-dione
  • Step 2 Compound 3-(((2-(4-(2-hydroxyethyl)piperazin-1-yl)ethyl)amino)methylene)-6-phenyldihydro-2H-pyran- Synthesis of 2,4(3H)-dione
  • Example 17A 3-(((2-(4-(2-hydroxyethyl)piperazin-1 -yl)ethyl)amino)methylene)-6-phenylpiperidine-2,4-di Ketone (compound 96
  • Step 1 Synthesis of the compound 3-((3-ethoxy-3-oxo-1-phenylpropyl)amino)-3-oxopropionic acid ethyl ester 3-amino-3-phenylpropionic acid Ethyl ester (4.31 g, 22.23 mmol), monoethyl malonate (4.47 g, 33.84 mmol),
  • Example 18 Compound 4-(((2-(4-(2-hydroxyethyl)piperazin-1-yl)ethyl)amino)methylene)-1 -phenylpiperidine-3,5- Synthesis of diketone (; compound 97;)
  • Step 2 Synthesis of the compound N-(2-oxopropyl)-N-phenylglycine ethyl ester
  • Phenylglycine ethyl ester (2.3 g 12.83 mmol), bromoacetone (2.1 1 g 25.67 mmol) and DIPEA (4.57 mL 25.67 mmol) were added to DMF (50 mL), and reacted at 10 ° C for 4 hours, supplemented with bromoacetone ( 1.06 g 12.8 mmol), continue to react at 1 10 ° C for 4 hours.
  • the mixture was poured into water, and extracted with EA.
  • the combined organic phase was dried over anhydrous sodium sulfate and evaporated.
  • Step 4 and 5 The procedure is the same as in Example 2.
  • Step 1 Synthesis of the compound ethyl 3-(phenylamino)propionate
  • Step 2 Synthesis of the compound 3-((3-ethoxy-3-oxopropyl)(phenyl)amino)-3-oxopropionate
  • Step 3 Synthesis of ethyl ester of compound ethyl-2,4-dioxo-l-phenylpiperidine-3-carboxylate
  • Step 5 Compound 3 -((( 2- ( 4- ( 2 -hydroxyethyl)piperazin-1-yl)ethyl)amino)methylene)-1-phenylpiperyl 1 ⁇ 2- 2 , 4 - 2 Ketone synthesis
  • Example 20 Compound 4-(4-fluorophenyl)-2-(((2-(4-(2-hydroxyethyl)piperazine-1-yl)ethyl)amino)methylene)cyclohexane -1,3-
  • Step 1 Synthesis of the compound 4-(4-fluorophenyl)cyclohexanyl -1 ,3-dione
  • Step 2 Compound 4-(4-fluorophenyl)-2-(((2-(4-(2-hydroxyethyl)piperazin-1-yl)ethyl)amino)methylene)cyclohexane- Synthesis of 1, 3-dione
  • Example 21 Compound 4-benzyl-2-(((2-(4-(2-hydroxyethyl))piperazinyl)ethyl)amino)methylene)-6-phenylcyclohexane- 1,3-diketone
  • Step 1 Synthesis of the compound 5-benzyl-4-phenylcyclohexanyl-1,3-dione
  • Step 2 Compound 4-benzyl-2-((2-(4-(2-hydroxyethyl)piperazin-1 -yl)ethyl)amino)methylene)-6-phenylcyclohexane Synthesis of -1,3-dione
  • Step 1 Synthesis of the compound ethyl (4-methoxybenzyl) glycine ethyl ester
  • Step 4 Compound 1-benzoyl-4-(((2-(4-(2-hydroxyethyl)piperazin-1 -yl)ethyl)amino)methylene)piperidine-3,5- Synthesis of diketone
  • Example 26 Compound 2-(((2-(4-(2-hydroxyethyl)piperazin-1-yl)ethyl)amino)methylene)-5-(morpholin-4-carbonyl) ring Synthesis of hexane-dione (compound 106)
  • Step 1 Synthesis of the compound 3-methoxy-5-oxocyclohex-3-ene-1-carboxylic acid
  • Step 2 Synthesis of the compound 3-methoxy-5-(morpholine-4-carbonyl)cyclohexane-2-dec-1-one
  • Step 4 Compound 2-(((2-(4-(2-hydroxyethyl))piperazinyl)ethyl)amino)methylene)-5-(indol-4-carbonyl)cyclohexane- Synthesis of 1,3-diketone
  • Example 27 Compound 3-(((2-(4-(2-hydroxyethyl)piperazin-1-yl)ethyl)amino)methylene)quinoline-2,4(1H, 3H)- Synthesis of diketone (; compound 107)
  • Step 1 Synthesis of the compound 3-oxo-3-(phenylamino)propionic acid methyl ester
  • Monomethyl malonyl chloride (1.84 g, 13.5 mmol) was added dropwise to an aniline solution of aniline (1.00 g, 10.74 mmol) and TEA (1.42 g, 14 mmol) at 0 ° C. Stir at room temperature for 30 minutes. After completion of the reaction, the reaction mixture was poured into water, EtOAc was evaporated, evaporated, evaporated, evaporated, evaporated. .
  • Step 3 Synthesis of the compound quinoline-2 1H, 3H)-dione
  • Step 4 Compound 3-(((2-(4-(2-hydroxyethyl)piperazin-1-yl)ethyl)amino)methylene)quinoline-2,4(1H, 3H)- Ketone synthesis
  • Example 28 Compound 2-(l-((2-(4-(2-hydroxyethyl)piperazin-1 -yl)ethyl)amino)ethylidene)-5-phenylcyclohexan-1 , 3-diketone (Compound 1
  • Acetyl chloride (4.2 g, 53.5 mmol) was added dropwise to 5-phenyl-1,3-cyclohexanedione (10.0 g, 53.1 mmol), DMAP (2.00 g, 16.4 mmol) and DIPEA (7.75 g). , 60 mmol) of the mixture was refluxed for 2 hours. Reaction completed
  • Step 2 Compound 2-(1-((2-(4-(2-hydroxyethyl)piperazin-1-yl)ethyl)amino)ethylidene)-5-phenylcyclohexan-1, Synthesis of 3-diketone
  • Compound 109-112 was synthesized in the same manner as Compound 107, as shown in Table 6.
  • Example 30 Compound 2-(((2-(4-(2-hydroxyethyl)piperazin-1-yl)ethyl)amino)methylene)-4a,9,10,10a-tetrahydrophenanthrene Single
  • Step 1 Synthesis of the compound ethyl 3-(2-bromophenyl)acrylate
  • Step 4 Compound 2-(((2-(4-(2-hydroxyethyl)piperazin-1-yl)ethyl)amino)methylene)-4a,9,10,10a-tetrahydrophenanthroline Synthesis of porphyrin-1,3(2H, 4H)-dione
  • Example 30B Compound 5-((2R, 3S, 4R, 5R)-3,4-dihydroxy-5-(6-morpholino-9H-indol-9-yl)tetrahydrofuran-2-yl)-2 Synthesis of - «(2-p- -1-yl)ethyl)amino)methylene)cyclohexanyl-1,3-dione (Compound 1 14)
  • Example 31 Compound 4-benzyl-2-(((2-(4-(2-hydroxyethyl)piperazin-1-yl)ethyl)amino)-methylene)cyclopentan-1, Synthesis of 3-diketone (; compound 115)
  • Step 1 Synthesis of the compound 5-benzyl-3-ethoxycyclopent-2-en-1-one
  • Step 3 Compound 4-benzyl-2-(((2-(4-(2-hydroxyethyl)piperazin-1-yl)ethyl)amino)methylene)-cyclopentan-1,3 -Diketone synthesis
  • Example 32 Compound 2-(((2-(4-(2-hydroxyethyl)piperazin-1 -yl)ethyl)amino)methylene)-4-methyl-5-phenylcyclohexane Alkane-1,3-two
  • Step 2 Compound 2-(((2-(4-(2-hydroxyethyl)piperazin-1 -yl)ethyl)amino)methylene)-4-methyl-5-phenylcyclohexane -1,3-dione synthesis
  • Example 34 Compounds 119-129, 131-143, 145-150, 155-156, 158, 160-165, 169-180, 182-197, 200-233, 236-243, 245-260, 262-274 Synthesis of 276-291, 293-311, 315, 317-318, 320-347 and 349-414
  • Oxocyclohexyl)benzene 7.40 (m, 2H), 3.94 (s, 3H), 3.52 - 3.35 (m,
  • Compound 415-452 was synthesized in the same manner as in Example 4 or 8 except for the corresponding substituted 1, 3-cyclohexanedione (e.g., Compounds 3 and 8), as shown in Table 8.
  • Step 1 Synthesis of 5-(; ethoxymethylene)-2,4-thiazolidinedione
  • Step 2 The synthesis procedure of the compound 5-(3 ⁇ 42-(4-(2-hydroxyethyl)piperazin-1-yl)ethyl)amino)methylene)thiazolium-2,4-dione
  • Example 2 (Compound 1)
  • Step 4 Synthesis of the compound 4-((dimethylamino)methylene)-2-methyl-2-phenylcyclobutane-1,3-dione (Compound 201)
  • Example 38 Compound 2-(((2-(Dimethylamino)ethyl)amino)methylene)-5-phenylcyclohexanyl-1,3-dione) Nickel chloride
  • Na forms a coordinate bond with a mercaptooxy group.
  • Li, Na or K forms a coordinate bond with the carbonyl oxygen.
  • Example 41 Modulation of the autophagy-associated protein LC3B by the compounds of the present invention was tested using the fluorescence polarization (FP) method. Fluorescence polarization (FP) test
  • Histone GST-LC3B final concentration 180 nM
  • SEQ ID NO: 1 ⁇ terminal FITC-labeled peptide
  • SEQ ID NO: 2 sequence: FITC-GGDDDWTHLSSKEVD-NH 2 , final concentration 18 nM
  • FP buffer 50 mM
  • HEPES pH 7.5, O.lmg/mL BSA, 1 mM DTT HEPES pH 7.5, O.lmg/mL BSA, 1 mM DTT
  • the IC 5Q value of the compound is expressed as: ⁇ ⁇ IC 50 ⁇ ImM is considered to be less active for LC3B (; +); compound 15 ⁇ ⁇ IC 50 ⁇ ⁇ is considered to be moderately active for LC3B C++); 3 ⁇ ⁇ IC 50 ⁇ 15 ⁇ is considered to be LC3B activity is high (+++); IC 50 ⁇ 3 ⁇ is considered to be highly active against LC3B (++++;).
  • the IC values of the compounds of the present invention are shown in Table 10.
  • the compounds of the present invention exhibit activity against LC3B, and some compounds have high activity against LC3B. These compounds are also active against other mammalian homologs of ATG8. Thus, these compounds can modulate LC3B and other mammalian homologs of ATG8 for the treatment of diseases associated with autophagy.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PCT/CN2018/087446 2017-05-22 2018-05-18 用作自噬调节剂的化合物及其制备方法和用途 Ceased WO2018214812A1 (zh)

Priority Applications (10)

Application Number Priority Date Filing Date Title
US16/614,465 US11319303B2 (en) 2017-05-22 2018-05-18 Compound used as autophagy regulator, and preparation method therefor and uses thereof
MX2019013816A MX2019013816A (es) 2017-05-22 2018-05-18 Compuesto usado como regulador de la autofagia, metodo de preparacion y sus usos.
AU2018274378A AU2018274378B2 (en) 2017-05-22 2018-05-18 Compound used as autophagy regulator, and preparation method therefor and uses thereof
BR112019024376-3A BR112019024376A2 (pt) 2017-05-22 2018-05-18 composto de fórmula geral (i), ou sais farmaceuticamente aceitáveis destes, composição farmacêutica e uso dos compostos ou sais farmaceuticamente aceitáveis destes
CA3061209A CA3061209A1 (en) 2017-05-22 2018-05-18 Compound used as autophagy regulator, and preparation method therefor and uses thereof
CN201880033785.9A CN111148740B (zh) 2017-05-22 2018-05-18 用作自噬调节剂的化合物及其制备方法和用途
KR1020197036203A KR102580087B1 (ko) 2017-05-22 2018-05-18 자가포식 조절인자(autophagy regulator)로서 사용된 화합물, 및 이에 대한 제조 방법 및 이의 용도
EP18805508.1A EP3632903B1 (en) 2017-05-22 2018-05-18 Compound used as autophagy regulator, and preparation method therefor and uses thereof
JP2019565459A JP7237017B2 (ja) 2017-05-22 2018-05-18 オートファジーモジュレーターとして使用される化合物、ならびにその調製方法および使用
CN202310882957.2A CN116969904A (zh) 2017-05-22 2018-05-18 用作自噬调节剂的化合物及其制备方法和用途

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201710364986.4A CN108947985A (zh) 2017-05-22 2017-05-22 用作自噬调节剂的化合物及其制备方法和用途
CN201710364986.4 2017-05-22

Publications (1)

Publication Number Publication Date
WO2018214812A1 true WO2018214812A1 (zh) 2018-11-29

Family

ID=64396259

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2018/087446 Ceased WO2018214812A1 (zh) 2017-05-22 2018-05-18 用作自噬调节剂的化合物及其制备方法和用途

Country Status (10)

Country Link
US (1) US11319303B2 (enExample)
EP (1) EP3632903B1 (enExample)
JP (1) JP7237017B2 (enExample)
KR (1) KR102580087B1 (enExample)
CN (3) CN108947985A (enExample)
AU (1) AU2018274378B2 (enExample)
BR (1) BR112019024376A2 (enExample)
CA (1) CA3061209A1 (enExample)
MX (1) MX2019013816A (enExample)
WO (1) WO2018214812A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021110010A1 (zh) * 2019-12-03 2021-06-10 微境生物医药科技(上海)有限公司 新型吡咯化合物

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108929373A (zh) * 2017-05-22 2018-12-04 苏州偶领生物医药有限公司 一种共价键修饰哺乳动物atg8 同源物的方法
CN111187153B (zh) * 2020-01-10 2022-09-13 山东亘元生物科技有限公司 一种1,3-环己二酮的制备方法
CN117440954A (zh) * 2021-04-20 2024-01-23 田纳西大学研究基金会 作为微管蛋白聚合抑制剂的代谢稳定的嘧啶基二氢喹喔啉酮
EP4326401A1 (en) 2021-04-20 2024-02-28 University of Tennessee Research Foundation Metabolically stable pyrimidinyl dihydroquinoxalinones as tubulin polymerization inhibitors
CN113956215B (zh) * 2021-07-15 2022-08-12 暨南大学附属第一医院 一种多环芳基化合物在抗真菌药物制备中的应用
US20250144110A1 (en) * 2022-01-28 2025-05-08 Washington University Compositions of autophagy modulating agents and uses thereof
CN114870569B (zh) * 2022-04-11 2023-04-07 合肥工业大学 一种哌嗪基碳捕集剂的合成方法
KR102800732B1 (ko) 2022-08-04 2025-05-13 신은식 띠지 포장용 난좌 가이드장치

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011033389A2 (en) * 2009-09-17 2011-03-24 Commissariat A L'energie Atomique Et Aux Energies Alternatives Plant additives and uses thereof to modulate the synthesis of membrane glycerolipids in planta

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6087238A (ja) * 1983-09-16 1985-05-16 ストウフアー・ケミカル・カンパニー ２‐（２‐置換ベンゾイル）‐１，３‐シクロヘキサンジオン
DE3474297D1 (en) * 1983-09-16 1988-11-03 Stauffer Chemical Co Certain 2-(2-substituted benzoyl)-1,3-cyclohexanediones
IL77349A (en) * 1984-12-20 1990-07-12 Stauffer Chemical Co 2-(2'-nitrobenzoyl)-1,3-cyclohexanediones,their preparation and their use as herbicides
JPS62123145A (ja) * 1985-11-22 1987-06-04 Otsuka Chem Co Ltd １，３−シクロヘキサンジオン誘導体及び該誘導体を有効成分とする水田用除草剤
WO2006007864A1 (en) * 2004-07-17 2006-01-26 Max Planck Geselllschaft Zur Förderung Der Wissenschaft Treating neurodegenerative conditions
NZ568656A (en) * 2005-12-23 2011-03-31 Basf Se A method for controlling aquatic weeds of the genus hydrilla with topramezone ([3-(4,5-dihydro-isoxazol-3-yl)-4-methylsulfonyl-2-methylphenyl](5-hydroxy-1-methyl-1H-pyrazol-4-yl)methanone)
GB2449293A (en) * 2007-05-17 2008-11-19 Evotec Compounds having Hsp90 inhibitory activity
JP2011507910A (ja) * 2007-12-21 2011-03-10 ユニバーシティー オブ ロチェスター 真核生物の寿命を変更するための方法
WO2011017809A1 (en) 2009-08-11 2011-02-17 The University Of British Columbia Autophagy inhibitor compounds, compositions and methods for the use thereof in the treatment of cancer
US8846747B2 (en) * 2009-11-17 2014-09-30 University Of Rochester Compounds and methods for altering lifespan of eukaryotic organisms
EP2508607A1 (en) * 2011-04-07 2012-10-10 Helmholtz-Zentrum für Infektionsforschung GmbH Medicament for liver regeneration and for treatment of liver failure
HK1206331A1 (en) * 2012-08-09 2016-01-08 Neuropore Therapies, Inc. Aryl-and heteroaryl-substituted benzene derivatives as modulators of pi3-kinase signalling pathways
CA2922925A1 (en) * 2013-09-05 2015-03-12 Genentech, Inc. Antiproliferative compounds
WO2016191872A1 (en) * 2015-06-01 2016-12-08 Dalhousie University S1pr2 antagonists and uses therefor
US20200123127A1 (en) * 2016-04-25 2020-04-23 Everon Biosciences, Inc. Removal of senescence-associated macrophages
CN108938612A (zh) * 2017-05-22 2018-12-07 苏州偶领生物医药有限公司 氨基亚甲基环己烷1,3-二酮化合物的用途
CN108929373A (zh) * 2017-05-22 2018-12-04 苏州偶领生物医药有限公司 一种共价键修饰哺乳动物atg8 同源物的方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011033389A2 (en) * 2009-09-17 2011-03-24 Commissariat A L'energie Atomique Et Aux Energies Alternatives Plant additives and uses thereof to modulate the synthesis of membrane glycerolipids in planta

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 24, no. 16, 2014, pages 3764 - 3771
BIOORGANIC & MEDICINAL CHEMISTRY, vol. 20, no. 2, 2012, pages 1029 - 1045
CANELA MARIA-DOLORES: "Targeting the colchicine site in tubulin through cyclohexanedione derivatives", RSC ADVANCES, vol. 6, no. 23, 9 February 2016 (2016-02-09), pages 19492 - 19506, XP055550396, ISSN: 2046-2069 *
CHEMISTRY - A EUROPEAN JOURNAL, vol. 20, no. 9, 2014, pages 2445 - 2448
DATABASE REGISTRY 1 August 2002 (2002-08-01), retrieved from STN Database accession no. 441740-08-5 *
HETEROCYCLES, vol. 28, no. 2, 1989, pages 1015 - 35
JOURNAL OF MEDICINAL CHEMISTRY, vol. 57, no. 10, 2014, pages 3924 - 3938
JOURNAL OF ORGANIC CHEMISTRY, vol. 66, no. 24, 2001, pages 8000 - 8009
JOURNAL OF ORGANIC CHEMISTRY, vol. 78, no. 9, 2013, pages 4563 - 4567
JOURNAL OF ORGANIC CHEMISTRY, vol. 82, no. 5, 2017, pages 2630 - 2640
TETRAHEDRON LETTERS, vol. 49, 2008, pages 4725 - 4727
TETRAHEDRON LETTERS, vol. 56, no. 45, 2015, pages 6287 - 6289

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021110010A1 (zh) * 2019-12-03 2021-06-10 微境生物医药科技(上海)有限公司 新型吡咯化合物
CN114206836A (zh) * 2019-12-03 2022-03-18 微境生物医药科技(上海)有限公司 新型吡咯化合物
JP2023505238A (ja) * 2019-12-03 2023-02-08 ウィゲン・バイオメディシン・テクノロジー・（シャンハイ）・カンパニー・リミテッド 新規ピロール化合物
CN114206836B (zh) * 2019-12-03 2023-10-13 微境生物医药科技(上海)有限公司 新型吡咯化合物
JP7746266B2 (ja) 2019-12-03 2025-09-30 ウィゲン・バイオメディシン・テクノロジー・（シャンハイ）・カンパニー・リミテッド 新規ピロール化合物
US12497397B2 (en) 2019-12-03 2025-12-16 Wigen Biomedicine Technology (shanghai) Co., Ltd. Pyrrole compounds useful as antifungals

Also Published As

Publication number Publication date
EP3632903A4 (en) 2021-03-17
CN111148740B (zh) 2023-08-25
JP2020521772A (ja) 2020-07-27
CN116969904A (zh) 2023-10-31
MX2019013816A (es) 2020-01-15
CN108947985A (zh) 2018-12-07
JP7237017B2 (ja) 2023-03-10
US11319303B2 (en) 2022-05-03
CN111148740A (zh) 2020-05-12
EP3632903A1 (en) 2020-04-08
AU2018274378B2 (en) 2022-08-04
CA3061209A1 (en) 2019-10-23
KR102580087B1 (ko) 2023-09-20
AU2018274378A1 (en) 2019-12-12
BR112019024376A2 (pt) 2020-07-14
KR20200008573A (ko) 2020-01-28
US20200190066A1 (en) 2020-06-18
EP3632903B1 (en) 2023-10-11

Similar Documents

Publication Publication Date Title
CN113999226B (zh) 作为kras抑制剂的杂环化合物的制备及其应用方法
WO2018214812A1 (zh) 用作自噬调节剂的化合物及其制备方法和用途
TWI680970B (zh) 可做為ｓｕｍｏ活化酵素抑制劑之雜芳基化合物
CN113173924B (zh) 一种作为cdk抑制剂的吡啶乙酰胺类衍生物、其制备方法及用途
CN112585118A (zh) 乙型肝炎衣壳装配调节剂
CN108779115B (zh) 五元杂芳环并桥环类衍生物、其制备方法及其在医药上的应用
CN116600808A (zh) 一类作为kras突变体g12c抑制剂的四氢萘啶类衍生物、其制备方法及其应用
WO2025051242A1 (zh) Ras抑制剂
CN112513041B (zh) 三环化合物
CN108779100A (zh) 3,4-二吡啶基吡唑类衍生物、其制备方法及其在医药上的应用
CN114478537A (zh) 环酰胺并环化合物及其医药用途
TW202510873A (zh) 蛋白質精胺酸酶甲基轉移酶－５抑制劑及其醫藥用途
CN112812105A (zh) 一种氨基吡啶基氧基吡唑类衍生物及其制备方法和应用
WO2016034634A1 (fr) Derives de n-aryl-2-amino-4-aryl-pyrimidines polyethers macrocycliques comme inhibiteurs de la ftl3 and jak
EP3720859A1 (en) Positive allosteric modulators of the muscarinic acetylcholine receptor m4
WO2022222911A1 (zh) 嘧啶酮化合物及其用途
WO2022171126A1 (zh) 作为Wee-1抑制剂的稠环化合物
JP7618898B1 (ja) ヒト呼吸器合胞体ウイルス及びメタニューモウイルスの阻害薬
HK40018032A (en) Compound used as autophagy regulator, and preparation method therefor and uses thereof
HK40018032B (zh) 用作自噬调节剂的化合物及其制备方法和用途
WO2024230586A1 (zh) 含二氮杂亚基磺酰结构的化合物作为pkm2激动剂的新用途
TWI707853B (zh) 1,2-二氫-1,6-萘啶類衍生物、其製備方法、其藥物組合物及其在醫藥上的用途
WO2025209520A1 (zh) 一种化合物、包含其的药物组合物及其用途

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18805508

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 3061209

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2019565459

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112019024376

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 20197036203

Country of ref document: KR

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2018274378

Country of ref document: AU

Date of ref document: 20180518

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2018805508

Country of ref document: EP

Effective date: 20200102

ENP Entry into the national phase

Ref document number: 112019024376

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20191119